โšกToday
โœจToday's leadDoctors Complete First Bone Marrow Transplant From Deceased Donor for Non-Malignant Disease๐ŸŽˆFor kidsSouth Carolina tract beside wildlife refuge to be permanently conserved๐ŸŒฟNatureFormer ocean liner S.S. United States becomes the world's largest artificial reefโšฝSportsLindy Duncan wins her first LPGA title on attempt 222๐ŸŽจCulture & ideasA Lost Altdorfer Landscape Surfaces After 70 Years Privately Held๐Ÿ”ฌScience & healthPeople who control HIV without treatment may help find a cure๐Ÿ’›KindnessA laid-off man began mowing lawns for free and 2,100 volunteers joined๐Ÿ›๏ธPoliticsLos Angeles bans oil drilling after a decade of neighborhood pressure๐Ÿš€ProgressPhiladelphia repaired a collapsed interstate in 12 days

Scientists publish first guidelines for phage therapy against superbugs

ScienceDaily 5 November 2026 2 min read

โฎ BeforeResistant infections often have few remaining antibiotic options.
โœ… NowAn international team has published the first coordinated guidelines for personalized phage therapy.

In short

  • An international team released the first coordinated guidelines for personalized phage therapy.
  • One study reported improvement in 77% of patients treated with the approach.
  • Targeted bacteria disappeared in 61% of patients, according to the same early findings.

Why it's good news

Antibiotic-resistant bacteria make some infections hard to treat with standard drugs. Phage therapy uses viruses that target specific bacteria, and the new guidelines give clinicians a shared route to use it safely. The treatment is still experimental, so the early results need larger trials to confirm them.

Advertisement

From ScienceDaily

Scientists are advancing a promising new way to fight antibiotic-resistant infections by using viruses that specifically target and kill harmful bacteria. An international team has released the first coordinated guidelines for personalized phage therapy, offering a roadmap for safely bringing this experimental treatment into clinical practice. Early findings are encouraging, with one study reporting improvement in 77% of patients and the disappearance of targeted bacteria in 61%.

Read the full story at ScienceDaily Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor